{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:35:22Z","timestamp":1792704922415,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Current therapy for preventing the first variceal bleed includes beta-blocker and variceal band ligation (VBL). VBL has lower bleeding rates, with no differences in survival, whereas beta-blocker therapy can be limited by side effects. Carvedilol, a non-cardioselective vasodilating beta-blocker, is more effective in reducing portal pressure than propranolol; however, there have been no clinical studies assessing the efficacy of carvedilol in primary prophylaxis. The goal of this study was to compare carvedilol and VBL for the prevention of the first variceal bleed in a randomized controlled multicenter trial. One hundred fifty-two cirrhotic patients from five different centers with grade II or larger esophageal varices were randomized to either carvedilol 12.5 mg once daily or VBL performed every 2 weeks until eradication using a multibander device. Seventy-seven patients were randomized to carvedilol and 75 to VBL. Baseline characteristics did not differ between the groups (alcoholic liver disease, 73%; median Child-Pugh score, 8; median age, 54 years; median follow-up, 20 months). On intention-to-treat analysis, carvedilol had lower rates of the first variceal bleed (10% versus 23%; relative hazard 0.41; 95% confidence interval 0.19-0.96 [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04]), with no significant differences in overall mortality (35% versus 37%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.71), and bleeding-related mortality (3% versus 1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.26). Six patients in the VBL group bled as a result of banding ulcers. Per-protocol analysis revealed no significant differences in the outcomes.\n                      <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                      Carvedilol is effective in preventing the first variceal bleed. Carvedilol is an option for primary prophylaxis in patients with high-risk esophageal varices. (Hepatology 2009.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.23045","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T18:38:54Z","timestamp":1240857534000},"page":"825-833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":244,"title":["Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed # \u2020"],"prefix":"10.1097","volume":"50","author":[{"given":"Dhiraj","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Leithead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Therapondos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma C.","family":"Mcavoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan H.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Hislop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20241201","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients.","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"R2-22-20241201","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.","volume":"40","author":"Carbonell","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R3-22-20241201","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","article-title":"Improving prognosis following a first variceal haemorrhage over four decades.","volume":"49","author":"McCormick","year":"2001","journal-title":"Gut"},{"key":"R4-22-20241201","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3748\/wjg.v9.i8.1836","article-title":"Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients.","volume":"9","author":"Cheng","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R5-22-20241201","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(90)91668-Z","article-title":"Metaanalysis of value of propranolol in prevention of variceal hemorrhage.","volume":"336","author":"Hayes","year":"1990","journal-title":"Lancet"},{"key":"R6-22-20241201","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/j.1572-0241.2007.01564.x","article-title":"Banding ligation versus betablockers as primary prophylaxis in esophageal varices: systematic review of randomized trials.","volume":"102","author":"Gluud","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R7-22-20241201","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MEG.0b013e3282748f07","article-title":"Variceal band ligation versus betablockers for primary prevention of variceal bleeding: a metaanalysis.","volume":"19","author":"Tripathi","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R8-22-20241201","first-page":"5714","article-title":"Pharmakologie und klinische pharmakologie des neuen vasodila tierenden betarezeptoren blockers BM 14190.","volume":"32","author":"Bartsch","year":"1982","journal-title":"Therapiewoche"},{"key":"R9-22-20241201","first-page":"611","article-title":"Hemodynamic effects of alphaadrenergic blockade with prazosin in cirrhotic patients with portal hypertension.","volume":"20","author":"Albillos","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R10-22-20241201","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1440-1746.1992.tb01018.x","article-title":"Effects of alpha 1 and betaadrenergic antagonists and 5hydroxytryptamine receptor antagonist on portalsystemic collateral vascular resistance in conscious rats with portal hypertension.","volume":"7","author":"Koshy","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-22-20241201","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840070406","article-title":"Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients.","volume":"7","author":"Vorobioff","year":"1987","journal-title":"HEPATOLOGY"},{"key":"R12-22-20241201","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","article-title":"Haemodynamic effects of acute and chronic administration of lowdose carvedilol, a vasodilating betablocker, in patients with cirrhosis and portal hypertension.","volume":"16","author":"Tripathi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-22-20241201","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","article-title":"Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis.","volume":"30","author":"Stanley","year":"1999","journal-title":"J Hepatol"},{"key":"R14-22-20241201","first-page":"353","article-title":"Effects of the alphabetablocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.","volume":"47","author":"Sekiyama","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"R15-22-20241201","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","article-title":"Acute administration of carvedilol is more effective than propranolol plus isosorbide5mononitrate in the reduction of portal pressure in patients with viral cirrhosis.","volume":"99","author":"Lin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R16-22-20241201","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0168-8278(96)80296-0","article-title":"Acute haemodynamic changes after oral carvedilol, a vasodilating betablocker, in patients with cirrhosis.","volume":"25","author":"Forrest","year":"1996","journal-title":"J Hepatol"},{"key":"R17-22-20241201","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1746.2002.02674.x","article-title":"Acute and 7day portal pressure response to carvedilol and propranolol in cirrhotics.","volume":"17","author":"De","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-22-20241201","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/00365520600780403","article-title":"Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.","volume":"41","author":"Bruha","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"R19-22-20241201","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective betablocker with intrinsic anti Alpha1adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.","volume":"30","author":"Banares","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R20-22-20241201","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of longterm carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.","volume":"36","author":"Banares","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R22-22-20241201","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.","volume":"33","author":"de Franchis","year":"2000","journal-title":"J Hepatol"},{"key":"R23-22-20241201","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","article-title":"Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.","volume":"340","author":"Sarin","year":"1999","journal-title":"N Engl J Med"},{"key":"R24-22-20241201","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2005.01.047","article-title":"Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with highrisk esophageal varices.","volume":"128","author":"Jutabha","year":"2005","journal-title":"Gastroenterology"},{"key":"R25-22-20241201","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00042737-200510000-00016","article-title":"Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial.","volume":"17","author":"Psilopoulos","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"R26-22-20241201","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1007\/BF01409476","article-title":"Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.","volume":"38","author":"Neugebauer","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"R27-22-20241201","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00005344-199219001-00028","article-title":"Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective firstpass extraction.","volume":"19","author":"Neugebauer","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"R28-22-20241201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/gast.2002.35385","article-title":"Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.","volume":"123","author":"Lui","year":"2002","journal-title":"Gastroenterology"},{"key":"R29-22-20241201","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1746.2005.04071.x","article-title":"Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.","volume":"21","author":"Lay","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R30-22-20241201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0016-5107(03)02819-0","article-title":"Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.","volume":"59","author":"Lo","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R31-22-20241201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.20284","article-title":"Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.","volume":"40","author":"Schepke","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R32-22-20241201","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10620-005-1619-8","article-title":"A randomized controlled trial of betablockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates.","volume":"50","author":"Thuluvath","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R33-22-20241201","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/lt.21083","article-title":"A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.","volume":"13","author":"Norberto","year":"2007","journal-title":"Liver Transpl"},{"key":"RU34-22-20241201","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1572-0241.2005.41864.x","article-title":"A randomized control trial of bimonthly versus biweekly endoscopic variceal ligation of esophageal varices.","volume":"100","author":"Yoshida","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R35-22-20241201","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1440-1746.2006.04169.x","article-title":"Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding.","volume":"21","author":"Harewood","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R36-22-20241201","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R37-22-20241201","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.20881","article-title":"Is banding ligation for primary prevention of variceal bleeding as effective as betablockers, and is it safe?","volume":"43","author":"Triantos","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R38-22-20241201","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.20593","article-title":"Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial.","volume":"41","author":"Shaheen","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R39-22-20241201","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.","volume":"131","author":"DAmico","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23045","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:28:26Z","timestamp":1733041706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23045","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164104.624778","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1164104.628381","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}